Biologics CRO Market Growth Driven by Rising Demand for Advanced Therapies

 The global biologics contract research organizations market size was estimated at USD 14.88 billion in 2025 and is projected to reach USD 32.30 billion by 2033, growing at a CAGR of 10.3% from 2026 to 2033. The market growth is driven by rising demand for biologics, increasing outsourcing trends among pharmaceutical companies, growing requirements for personalized medicine, and cell & gene therapies. As biologic drug development becomes increasingly complex, pharmaceutical and biotechnology companies are relying on contract research organizations (CROs) to access specialized expertise, improve operational efficiency, and accelerate development timelines. The growing focus on innovative therapies and advanced biologic products is further supporting market expansion globally.

Biologics contract research organizations provide a wide range of research and development services that support biologic drug discovery, preclinical studies, clinical trials, regulatory compliance, data management, and commercialization activities. These organizations help sponsors manage the complexities associated with biologic products, including monoclonal antibodies, recombinant proteins, vaccines, cell therapies, and gene therapies. Increasing investments in biotechnology research and the rising number of biologic candidates entering development pipelines continue to drive demand for CRO services across global healthcare markets.

Download a free sample copy of the Biologics Contract Research Organizations market report to understand detailed coverage and inclusions in the final report

Key Market Trends & Insights

  • Asia Pacific biologics contract research organizations (CRO) market held the largest share of 47.1% of the global market in 2025. The region's leadership is supported by expanding pharmaceutical and biotechnology industries, increasing clinical research activities, a large patient population, and cost-effective research capabilities. Growing investments in healthcare infrastructure and supportive government initiatives aimed at strengthening life sciences research are contributing significantly to market growth. The availability of skilled research professionals and expanding clinical trial capabilities further reinforce the region's dominant position.
  • The biologics contract research organizations (CRO) market in India is expected to grow significantly from 2026 to 2033. India has emerged as an important destination for clinical research and biologics development due to its strong scientific talent pool, expanding biotechnology sector, and competitive operating costs. Increasing investments in pharmaceutical innovation, growing research collaborations, and rising participation in global clinical trials are supporting the expansion of biologics CRO services across the country. Continued advancements in healthcare infrastructure are expected to further strengthen market growth.
  • In 2025, the clinical segment held the largest market share of 75.6% by type. Clinical research services represent a critical stage in biologic drug development, requiring extensive evaluation of safety, efficacy, dosing, and regulatory compliance. The increasing number of biologics entering clinical development and the growing complexity of clinical trial protocols are driving demand for specialized clinical CRO services. Sponsors continue to rely on experienced organizations to manage trial execution, patient recruitment, monitoring, and data analysis activities.
  • Based on product, monoclonal antibodies (mAbs) segment held the largest share in 2025. Monoclonal antibodies remain one of the most important categories within biologic therapeutics due to their widespread use in treating cancer, autoimmune disorders, infectious diseases, and other chronic conditions. The growing number of approved mAb therapies and expanding research efforts focused on developing next-generation antibody-based treatments are contributing significantly to the segment's leadership. Continued innovation in antibody engineering and targeted therapies is expected to support sustained growth within this category.
  • In 2025, the clinical monitoring segment emerged as a leading service category. Clinical monitoring services are essential for ensuring study quality, regulatory compliance, patient safety, and data integrity throughout the clinical trial process. Effective monitoring helps sponsors maintain protocol adherence, identify potential risks, and ensure reliable study outcomes. As biologics trials become increasingly complex and multinational in scope, demand for comprehensive clinical monitoring services continues to grow, supporting the segment's strong market position.

Looking for more specific insights? Customize this report to suite your business needs

Key Companies & Market Share Insights

The biologics CRO market is moderately fragmented, with a mix of large global CRO platforms and specialized regional providers. Some of the key players such as Lonza Group AG, WuXi Biologics, Samsung Biologics, Catalent, Inc., and Thermo Fisher Scientific are advancing the market through various strategic initiatives. These firms hold significant shares through integrated service offerings. In addition, mid-sized companies such as Parexel International and IQVIA compete through clinical trial capabilities and global site networks. Strategic collaborations and acquisitions remain key competitive approaches.

Key Biologics Contract Research Organizations Companies:

  • Lonza Group AG
  • WuXi Biologics / WuXi AppTec
  • Samsung Biologics
  • Catalent, Inc.
  • Fujifilm Diosynth Biotechnologies
  • AGC Biologics
  • Thermo Fisher Scientific (Patheon)
  • Boehringer Ingelheim (BioXcellence)
  • Charles River Laboratories
  • Parexel International
  • IQVIA
  • Medpace Holdings, Inc.
  • Syngene International
  • Eurofins Scientific
  • KBI Biopharma

Explore Grand View Horizon to see global and regional level statistics related to the Biologics Contract Research Organizations Market

Grand View Research offers

  • Focused market intelligence reports on specific geographies or high-growth segments.
  • Extended forecast timelines for long-term planning.
  • Competitor Benchmarking and Supply Chain Analysis
  • Inclusion of regulatory and policy assessments.
  • Inclusion of custom data models, KPIs, or applications unique to your business
  • Specific high-impact Data Decks and Tables to support effective decision making
  • And much more…

Looking for a report customized to your requirements? Explore our Custom Research Offering

Comments

Post a Comment

Popular posts from this blog

Smart Glass Market Is Projected To Grow Robustly By 2030

  Smart Glass Industry The global smart glass market size was estimated at USD 6.59 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 9.9% from 2023 to 2030. The growing energy-conservation initiatives, such as green buildings and eco-friendly structures are expected to drive the market expansion. Moreover, favorable regulatory scenario facilitating financial and tax benefits is also positively influencing the market space. Rise in developments, including an increase in investment level and the establishment of industrial-scale production capacity, has contributed to the glass industry's growth. Recent trends in modern architecture, such as extensive use of window structures inside the buildings, increasing area of glazing, and maximizing external environment interference, are fueling the demand for smart solutions. Moreover, in multi-story buildings, smart device solution solves the problem of energy-saving and safety concerns. Many building owners...
Read more

Clinical Alarm Management Market 2024 Trend, Marketing Channels and Investment Feasibility

  Clinical Alarm Management Industry The global clinical alarm management market size was estimated at USD 2.13 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 17.0% from 2024 to 2030. Growing cases of alarm fatigue and the need for cost-containment are the factors expected to boost market growth. Furthermore, prolonged hospital stays coupled with technological advancements in this sector and rising prevalence of various chronic diseases are most likely to fuel market growth. Increasing cases of alarm fatigue are expected to boost the demand for alarm management solutions as well as services. Alarm fatigue is a significant concern in healthcare, leading to excessive non-actionable alarms that can compromise patient safety. The Making Health Care Safer (MHCS) reports from the Agency for Healthcare Research and Quality (AHRQ) emphasize implementing safety culture elements, risk assessments, and training to reduce alarm burden and improve overall pat...
Read more

Travel Insurance Market Is Projected To Grow Robustly By 2030

  Travel Insurance Industry The global  travel insurance market  size was estimated at USD 27.05 billion in 2024 and is projected to grow at a CAGR of 15.4% from 2025 to 2030. The growth of the market can be attributed to the growing popularity of travel and tourism and the subsequent awareness about buying dedicated insurance coverage covering various unforeseen events, such as flight delays, loss of luggage and other personal effects, and cancellation of trips, occurring while traveling. Furthermore, the adoption of travel insurance is gaining traction as advances in technology are allowing to bundle travel insurance purchases with online ticket booking, thereby contributing to the growth of the market. Several insurance companies across the globe are striking partnerships with other insurance companies to launch travel insurance policies and provide comprehensive coverage at competitive rates. For instance, in October 2023, Trawick International, an insurance company, ...
Read more